tiprankstipranks
Benitec Biopharma Showcases Encouraging Clinical Trial Results
PremiumCompany AnnouncementsBenitec Biopharma Showcases Encouraging Clinical Trial Results
28d ago
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
PremiumPress Releases
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
28d ago
Benitec Biopharma reports interim trial data for subject treasted with BB-301
PremiumThe Fly
Benitec Biopharma reports interim trial data for subject treasted with BB-301
28d ago
Benitec Biopharma price target raised to $10 from $8 at JMP Securities
PremiumThe FlyBenitec Biopharma price target raised to $10 from $8 at JMP Securities
3M ago
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
PremiumPress Releases
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
3M ago
Benitec Biopharma reports Q2 EPS ($2.64) vs ($3.34) last year
PremiumThe Fly
Benitec Biopharma reports Q2 EPS ($2.64) vs ($3.34) last year
3M ago
Benitec Biopharma reports Q1 EPS ($2.76) vs. ($7.98) last year
PremiumThe FlyBenitec Biopharma reports Q1 EPS ($2.76) vs. ($7.98) last year
6M ago
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
PremiumPress Releases
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
6M ago
BNTC Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BNTC Upcoming Earnings Report: What to Expect?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100